On January 23, 2026, the Board of Directors resolved to propose the adoption of the 2026 Share Scheme. On the same date, pursuant to the 2026 Share Scheme, the company conditionally granted a total of 2 million restricted share units to Dr. Peng Jun (Chairman of the Board, Executive Director, Chief Executive Officer, and one of the company's beneficiaries with different voting rights) and Dr. Lou Tiancheng (Executive Director, Chief Technology Officer, and one of the company's beneficiaries with different voting rights).